Vaccines growth offsets Advair generic pain for GSK

25-07-2019

Sarah Morgan

Vaccines growth offsets Advair generic pain for GSK

will barton / Shutterstock.com

Growth in GlaxoSmithKline’s (GSK) vaccines and consumer healthcare divisions has managed to partly counter the impact of generic versions of Advair (fluticasone propionate/salmeterol) on its sales.


GSK, GlaxoSmithKline, Advair, generics, patent cliff, results, vaccines, Emma Walmsley, Tesaro, R&D

LSIPR